Babak Amirshahi Shirazi, MD
Internal Medicine · Hyattsville, MDNPI 1255649695
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Aroa Biosurgery Incorporated at 23.6% of the total. That places this record below the midpoint for internal medicine clinicians in MD, where the typical reported total is $161.
Across 8 payments — averaging $21.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aroa Biosurgery Incorporated$40
- Medtronic$38
- Johnson & Johnson$28
- Fisher & Paykel Healthcare Inc$26
- Mckesson Patient Care Solutions Inc.$21
- AbbVie$17
What the payments were for
- Food & beverage$171100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aroa Biosurgery Incorporated | 1 | $40 |
| Medtronic | 2 | $38 |
| Johnson & Johnson | 2 | $28 |
| Fisher & Paykel Healthcare Inc | 1 | $26 |
| Mckesson Patient Care Solutions Inc. | 1 | $21 |
| AbbVie | 1 | $17 |
How this compares
$171 in reported general payments places this provider in the 50th percentile of 2,979 internal medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,310 |
| Cefdinir | 28 | $423 |
| Pantoprazole Sodium | 16 | $134 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Hyattsville
- Marianne MannHighland$2.1M
- Param DedhiaBaltimore$636K
- Curtis RosebraughAshton$418K
- Mark CorriereColumbia$402K
- Gregory PokrywkaTowson$377K
- Shawn DhillonBaltimore$227K
- Brian HarveyAnnapolis$220K
- Jeremy SugarmanBaltimore$210K
- Florence HounPotomac$161K
- Matthew MintzBethesda$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.